Bausch Health CompaniesBHC
紐約證券 · USD
5.05
-0.38
(-7.00%)
收盤 03/13 03:59 (UTC+8)
03/13 03:59 (UTC+8)
Bausch Health CompaniesBHC
5.05
-0.38
(-7.00%)
財務數據
損益表
- 22.38
- 24.08
- 21.53
- 24.03
- 25.10
- 25.59
- 22.59
- 25.30
- 26.81
- 27.96
- 3.28
- 7.60
- -10.59
- 11.61
- 4.45
- 1.95
- -11.72
- 12.00
- 5.97
- 4.29
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 2,796,000 | 2,681,000 | 2,530,000 | 2,259,000 | 2,559,000 | 2,510,000 | 2,403,000 | 2,153,000 | 2,408,000 | 2,238,000 |
營業成本 | 798,000 | 750,000 | 764,000 | 701,000 | 727,000 | 696,000 | 719,000 | 640,000 | 705,000 | 623,000 |
營業毛利 | 1,998,000 | 1,931,000 | 1,766,000 | 1,558,000 | 1,832,000 | 1,814,000 | 1,684,000 | 1,513,000 | 1,703,000 | 1,615,000 |
營業費用 | 1,524,000 | 1,312,000 | 1,322,000 | 1,282,000 | 1,274,000 | 1,496,000 | - | - | 1,341,000 | 1,601,000 |
研發費用 | 161,000 | 166,000 | 159,000 | 143,000 | 163,000 | 146,000 | 156,000 | 151,000 | 152,000 | 153,000 |
推銷及管理費用 | 947,000 | 875,000 | 876,000 | 882,000 | 822,000 | 1,075,000 | 852,000 | 794,000 | 794,000 | 775,000 |
非經常性項目費用 | 180,000 | 18,000 | 31,000 | 1,000 | 30,000 | 1,000 | 17,000 | 13,000 | 113,000 | 420,000 |
其他營業費用 | 236,000 | 253,000 | 256,000 | 256,000 | 259,000 | 274,000 | 270,000 | 274,000 | 282,000 | 253,000 |
營業利益 | 829,000 | 619,000 | 444,000 | 276,000 | 558,000 | 318,000 | 389,000 | 281,000 | 362,000 | 14,000 |
其他收入及費用 | -21,000 | 11,000 | 161,000 | 7,000 | -12,000 | 7,000 | 9,000 | 5,000 | -6,000 | -1,000 |
利息費用 | 397,000 | 412,000 | 465,000 | 330,000 | 337,000 | 346,000 | 350,000 | 355,000 | 363,000 | 339,000 |
稅前純益 | 56,000 | 218,000 | 140,000 | -47,000 | 209,000 | -21,000 | 48,000 | -69,000 | -7,000 | -326,000 |
所得稅 | 159,000 | 37,000 | 12,000 | 39,000 | 111,000 | 71,000 | 49,000 | 8,000 | 40,000 | 56,000 |
稅後純益 | -112,000 | 179,000 | 148,000 | -58,000 | 93,000 | -85,000 | 10,000 | -64,000 | -39,000 | -378,000 |
基本每股稅後盈餘(元) | -0.30 | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 | 0.03 | -0.17 | -0.11 | -1.03 |
稀釋每股稅後盈餘(元) | -0.30 | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 | 0.02 | -0.17 | -0.10 | -1.04 |
基本平均股數(千股) | 373333.00 | 372916.00 | 370900.00 | 362500.00 | 372000.00 | 369565.00 | 367900.00 | 376470.00 | 354545.00 | 366990.00 |
稀釋平均股數(千股) | 373333.00 | 372916.00 | 373100.00 | 362500.00 | 372000.00 | 369565.00 | 370200.00 | 376470.00 | 354545.00 | 366990.00 |
還原基本每股稅後盈餘(元) | -0.30 | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 | 0.03 | -0.17 | -0.11 | -1.03 |
還原稀釋每股稅後盈餘(元) | -0.30 | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 | 0.02 | -0.17 | -0.10 | -1.04 |
還原基本平均股數(千股) | 373,333 | 372,916 | 370,900 | 362,500 | 372,000 | 369,565 | 367,900 | 376,470 | 354,545 | 366,990 |
還原稀釋平均股數(千股) | 373,333 | 372,916 | 373,100 | 362,500 | 372,000 | 369,565 | 370,200 | 376,470 | 354,545 | 366,990 |
EBITDA(千元) | 758,000 | 970,000 | 993,000 | 653,000 | 883,000 | 688,000 | 761,000 | 653,000 | 730,000 | 346,000 |